The latest biotech news - Labiotech.eu

Home News and Trends Page 197

Latest Posts

Zenome Network Genomic Internet

News and Trends 17 Sep 2018

The First ‘Genomic Internet’ Has Been Launched

The Russian non-profit Zenome.io has launched today the beta release of the first decentralized ‘genomic internet’, which is expected to make possible the safe storage of large amounts of genetic data. Genomics is one of the largest generators of data on the internet, more than Twitter and YouTube according to Zenome. Using a decentralized network […]

September 17, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Chicken feeding Novozymes

News and Trends 14 Sep 2018

Novozymes Releases Enzyme That Helps Chickens Better Absorb Food

Novozymes has released a new enzyme that breaks down bacterial cell debris in the gut and allows chickens to absorb more nutrients from their food. The Danish industrial biotech giant partnered with the Dutch health and nutrition company DSM to produce the bacterial muramidase enzyme solution, which is called ‘Balancius’. It has an interesting story […]

September 14, 2018 - 2 minutesmins - By Helen Albert

$bone Therapeutics cell therapy bone fracture$

News and Trends 14 Sep 2018

Cell Therapy Helps Regenerate Difficult Bone Fractures

All patients in a clinical trial run by the Belgian company Bone Therapeutics have seen an improvement in the healing of bone fractures that have had problems healing. Six months after receiving a single dose of the cell therapy developed by Bone Therapeutics, all 21 patients in the Phase I/IIa clinical trial met the primary […]

September 14, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Airbus AMSilk spider silk planes

News and Trends 12 Sep 2018

Airbus Will Use Recombinant Spider Silk to Build Lightweight Planes

Airbus has signed a partnership with German biotech AMSilk for the development of a new biomaterial to be used in the construction of future high-performance planes. Spider silk is known for having outstanding strength and flexibility. AMSilk uses engineered bacteria to produce spider silk protein, which is then used to create materials with a wide […]

September 12, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

diabetes insulin pump Arecor

News and Trends 10 Sep 2018

Cambridge Biotech Targets Artificial Pancreas Market With Fast Insulin and Stable Glucagon

UK biotech Arecor has raised €6.7M to help fund development of its extra-fast insulin and stable glucagon products for people with insulin-dependent diabetes. The speed of action of insulin has been a limiting factor for development of the artificial pancreas — a combined insulin pump and glucose monitor that would allow real-time control of blood […]

September 10, 2018 - 2 minutesmins - By Helen Albert

Type 1 Diabetes AG019

News and Trends 10 Sep 2018

Update: Non-Invasive Glucose Monitoring Device Moves Forward With Series B Funding

Update (10/09/2018): RSP Systems has raised an additional €3.85M that raises the total amount of its Series B fundraising to €10.35M. The funds will be used to run clinical trials with the company’s device, which measures blood sugar without the need for finger-pricking. Published on 11/06/2018 RSP Systems has raised €6.5M in the first closing […]

September 10, 2018 - 2 minutesmins - By Alexander Burik

ADVERTISEMENT

More Brexit Bad news EMA header

News and Trends 6 Sep 2018

More Brexit Bad News: EMA Pulls Contracts Early From UK Regulatory Body

The European Medicines Agency (EMA) has pulled all contracts with the UK’s medical regulation body ahead of the UK withdrawing from the EU next year. Until 2018, the EMA has relied on the UK Medicines & Healthcare products Regulatory Agency (MHRA) to assess 20–30% of its drugs on a contract basis, work worth approximately €15.6M […]

September 6, 2018 - 2 minutesmins - By Helen Albert

Adocia Biochaperone insulin pramlantide

News and Trends 6 Sep 2018

Insulin Combo Reduces After-Meal Sugar Spikes in Type 1 Diabetics

In the midst of a legal litigation with Eli Lilly, Adocia has released Phase 1 data showing its insulin combo can outperform Lilly’s fast-acting insulin in keeping sugar levels low after a meal. The trial, which recruited 24 type 1 diabetics, studied the effect of Adocia’s BioChaperone pramlintide insulin on glucose levels right after […]

September 6, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Cassava plantation CRISPR editing story

News and Trends 5 Sep 2018

Cassava Plants Gene Edited Using CRISPR to Produce Waxy Starch

A team of European researchers applied CRISPR-Cas9 gene editing technology to engineer cassava plants that produce a modified type of starch, in demand for both cooking and industrial processing. The team also managed to speed up the flowering of the plants by introduction of a gene from Arabidopsis plants, which they hope will allow more […]

September 5, 2018 - 3 minutesmins - By Helen Albert

ProQR RNA Genetic Blindness

News and Trends 5 Sep 2018

RNA Therapy Improves Vision in Patients with Rare Genetic Blindness

Dutch company ProQR has released data from a Phase I/II trial showing its RNA therapy can improve the vision of people with a rare form of hereditary blindness. The clinical trial recruited 10 people with the rare disease Leber’s congenital amaurosis 10. Caused by mutations in a gene called CEP290, this condition leads to […]

September 5, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Ablynx nanobody Cablivi caplacizumab

News and Trends 4 Sep 2018

The EMA Approves the First Nanobody from Ablynx

Update: The EMA has officially approved Cablivi for the treatment of adults with acquired thrombotic thrombocytopenic purpura, following its earlier recommendation in June. The drug has also been accepted for priority review by the US FDA, with a decision due on 6 Feb 2019. Published 29.6.18 Just a few months after Sanofi acquired Ablynx in a multi-billion euro […]

September 4, 2018 - 2 minutesmins - By Editorial Team

Evox Therapeutics drug delivery

News and Trends 3 Sep 2018

Oxford Biotech Raises €40M to Deliver Drugs to Hard-to-Reach Targets

Evox Therapeutics has raised £35.5M (€39.4M) in a Series B fundraising that has been backed, among others, by the venture arm of Google’s parent company. A spin-out from the University of Oxford and the Karolinska Institute, Evox Therapeutics has raised a large round that will fund the development of its drug delivery technology to […]

September 3, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

ADVERTISEMENT